FIELD: medicine.
SUBSTANCE: invention relates to a method for prediction of probability of developing cardiovascular diseases in patients with neurocirculatory dystonia with symptoms of connective tissue dysplasia. Method consists in the fact that collagen antibodies of second and third type are examined in venous blood and prediction coefficient of probability of developing cardiovascular diseases is calculated by formula. If the coefficient K varies from 0.6 to 1.59 a minimum probability of hypertensive heart disease exists, if varies from 1.6 to 2.59 it means a probability of developing hypertension, exceeding 2.6 means a probability of developing ischemic heart disease.
EFFECT: using the declared method enables more effective prediction of risk of cardiovascular diseases in patients with neurocirculatory dystonia with symptoms of connective tissue dysplasia.
1 cl, 4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE RISK OF DEVELOPING ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS COMBINED WITH SUBCLINICAL HYPOTHYROIDISM | 2018 |
|
RU2691937C1 |
METHOD FOR PREDICTION OF THE RISK OF DEVELOPING ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS COMBINED WITH SUBCLINICAL THYROTOXICOSIS | 2018 |
|
RU2691620C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING ACUTE LEFT VENTRICULAR FAILURE IN THE FORM OF CARDIOGENIC SHOCK OR PULMONARY EDEMA IN PATIENTS WITH ACUTE CORONARY SYNDROME IN COMBINATION WITH THE SYNDROME OF UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA | 2022 |
|
RU2782490C1 |
METHOD FOR PREDICTING THE RISK OF PROGRESSING CHRONIC HEART FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION | 2019 |
|
RU2734671C1 |
METHOD FOR PREDICTION OF ISCHEMIC HEART DISEASE IN FEMALES WITH POLYCYSTIC OVARIAN SYNDROME | 2012 |
|
RU2480758C1 |
METHOD FOR PREDICTING RISK OF ISCHEMIC STROKE IN PATIENTS WITH MYOCARDIAL INFARCTION | 2020 |
|
RU2760854C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF CARDIOPSYCHONEUROSIS IN MALES | 2010 |
|
RU2432111C1 |
METHOD FOR PREDICTING RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE, HAVING UNDERGONE PLANNED ENDOVASCULAR MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770273C1 |
METHOD FOR PREDICTION OF DEVELOPMENT OF LIFE-THREATENING AURICULAR ARRYTHMIA IN PATIENTS WITH HYPERTENSION DISEASE | 2016 |
|
RU2634246C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF ATRIAL FIBRILLATION IN WOMEN WITH CORONARY HEART DISEASE | 2017 |
|
RU2657942C1 |
Authors
Dates
2016-09-20—Published
2014-12-15—Filed